CD8A and neoplasm: Similarly, B16 can be controlled with as few as 104 infused tumor-specific CD8 T cells (15), and where B16 tumor implantation does not generate sufficient T cells to control tumor growth, expansion of these cells ex vivo followed by adoptive transfer is protective (16).